Cargando…

Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey

BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to se...

Descripción completa

Detalles Bibliográficos
Autores principales: Usta, Nuray Can, Kartal, Seyfi, Gunay, Betul Onal, Boz, Cavit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321161/
https://www.ncbi.nlm.nih.gov/pubmed/37551396
http://dx.doi.org/10.2478/abm-2022-0004
_version_ 1785068569701122048
author Usta, Nuray Can
Kartal, Seyfi
Gunay, Betul Onal
Boz, Cavit
author_facet Usta, Nuray Can
Kartal, Seyfi
Gunay, Betul Onal
Boz, Cavit
author_sort Usta, Nuray Can
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure. OBJECTIVES: To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19. METHODS: Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design. RESULT: We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus. CONCLUSION: COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present.
format Online
Article
Text
id pubmed-10321161
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-103211612023-08-07 Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey Usta, Nuray Can Kartal, Seyfi Gunay, Betul Onal Boz, Cavit Asian Biomed (Res Rev News) Original Article BACKGROUND: Coronavirus disease 2019 (COVID-19) can affect the neurological as well as the respiratory system. Neurological manifestations may involve the central or peripheral nervous systems, or musculoskeletal system. Findings can range from mild presentations, such as headache and anosmia, to severe complications, such as stroke and seizure. OBJECTIVES: To evaluate the neurological findings and to determine etiological risk factors for mortality in patients hospitalized for COVID-19. METHODS: Medical records of patients with COVID-19 who were hospitalized and sought neurological consultation between March 2020 and March 2021 at a reference pandemic hospital in Turkey were reviewed retrospectively in a cross-sectional study design. RESULT: We included data from 150 (94 male) patients. Their mean age ± standard deviation was 68.56 ± 16.02 (range 21–97) years. The patients were categorized into 2 groups according to any acute neurological event or progression of neurological disease. Ischemic cerebrovascular events, seizures, and encephalopathy were the most common acute neurological events, while deterioration in consciousness, epileptic seizures, and Parkinson disease were observed in those with progression of neurological disease. Abnormal neurological findings were found at a mean of 7.8 ± 9.7 days following COVID-19 diagnosis and 50 (a third of) patients died. A logistic regression model found that advanced age, increased Modified Charlson Comorbidity Index (MCCI) score, and prolonged duration of hospitalization were factors significantly associated with increased mortality; however, sex and day of abnormal neurological findings after COVID-19 diagnosis were not. Common conditions accompanying neurological events were hypertension, coronary artery disease–heart failure, and diabetes mellitus. CONCLUSION: COVID-19 may present with neurological symptoms in our Turkish patients and comorbidities are often present. Sciendo 2022-02-28 /pmc/articles/PMC10321161/ /pubmed/37551396 http://dx.doi.org/10.2478/abm-2022-0004 Text en © 2022 Nuray Can Usta et al., published by Sciendo https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Original Article
Usta, Nuray Can
Kartal, Seyfi
Gunay, Betul Onal
Boz, Cavit
Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title_full Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title_fullStr Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title_full_unstemmed Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title_short Neurological manifestations and etiological risk factors in patients hospitalized with COVID-19 in Turkey
title_sort neurological manifestations and etiological risk factors in patients hospitalized with covid-19 in turkey
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321161/
https://www.ncbi.nlm.nih.gov/pubmed/37551396
http://dx.doi.org/10.2478/abm-2022-0004
work_keys_str_mv AT ustanuraycan neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey
AT kartalseyfi neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey
AT gunaybetulonal neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey
AT bozcavit neurologicalmanifestationsandetiologicalriskfactorsinpatientshospitalizedwithcovid19inturkey